Investment Trusts

Templeton Emerging Markets Investment Trust TEMIT

TEM:LSE

Templeton Emerging Markets Investment Trust TEMIT

  • Price (GBX)164.60
  • Today's Change-0.40 / -0.24%
  • Shares traded1.98m
  • 1 Year change9.73%
  • Beta0.7112
Data delayed at least 20 minutes, as of Nov 21 2024 16:40 GMT.
More ▼
Total returns on £1000
1Y
Fund/benchmarkChange
PriceTempleton Emerging Markets Investment Trust TEMIT (Ordinary Share)+12.97%
NAVTempleton Emerging Markets Investment Trust TEMIT (Ordinary Share)+15.06%
Morningstar's BenchmarkMSCI Emerging Markets GBP--

Key statistics

On Thursday, Templeton Emerging Markets Investment Trust TEMIT (TEM:LSE) closed at 164.60, -6.05% below its 52-week high of 175.20, set on Oct 07, 2024.
52-week range
Today
141.00Jan 17 2024175.20Oct 07 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding1.05bn
Market cap1.74bn GBP
Total assets2.15bn GBP
Total expense ratio0.97%
High166.00
Low164.20
Previous close165.00
Average volume1.42m
YTD Change+8.58%
Beta0.7112
Diluted NAV (est)193.75
Diluted NAV (last pub)194.64
Premium/Discount-15.05%
Net Gearing0.00%
Annual div (ADY)5.00 GBX
Annual div yield (ADY)3.03%
Div ex-dateJun 20 2024
Div pay-dateJul 26 2024
Data delayed at least 20 minutes, as of Nov 21 2024 16:40 GMT.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.